Observational Study of the HemoCept Device During Diagnostic Right Heart Catheterization for Pulmonary Hypertension and Heart Conditions

What this Trial Is About

This observational pilot study aims to collect data from the HemoCept device in patients undergoing diagnostic right heart catheterization procedures. The study focuses on conditions such as pulmonary hypertension, congestive heart failure, and heart valve disease. It is sponsored by HemoCept Inc. and seeks to understand the association between device measurements and pulmonary capillary wedge pressure on the first day of the procedure. Participants will undergo diagnostic right heart catheterization, which may be combined with left heart catheterization, but left-heart-only procedures are not included. This study does not involve any experimental treatments or interventions but focuses on monitoring and collecting data during the catheterization process using the HemoCept device. During the study, participants will be monitored as the device collects data related to heart function. Researchers will assess the devices measurements and compare them to pulmonary capillary wedge pressure to evaluate its performance. The study requires informed consent and HIPAA authorization, with participant involvement mainly centered around the scheduled catheterization procedure and associated data collection.

Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization